New hope for tiniest lungs: testing a gentler steroid to prevent chronic breathing problems in preemies
NCT ID NCT06589245
Summary
This study is testing the safety of an inhaled steroid called ciclesonide in premature infants who are at high risk for developing a serious chronic lung condition called bronchopulmonary dysplasia (BPD). The goal is to see if this medication, which is already approved for asthma in older children, can be absorbed safely by preemies' bodies without causing harmful side effects like high blood sugar or stunted growth that are linked to other steroids. Researchers will enroll 30 very premature infants who are on a breathing machine to closely monitor them for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Mercy Kansas City
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.